Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity

Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance

(2022) YUNMOON OH et al.   ANTICANCER RESEARCH

JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells

(2022) Yunmoon Oh et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells

(2021) CHUNXUE JIANG et al.   ANTICANCER RESEARCH

Therapeutic strategies to overcome taxane resistance in cancer

(2021) Tuyelee Das et al.   DRUG RESISTANCE UPDATES

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

(2021) Sungpil Yoon et al.   Frontiers in Oncology

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

(2021) Christina Pfab et al.   Cancers

Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells

(2021) CHUNXUE JIANG et al.   ANTICANCER RESEARCH

Perplexing Role of P-Glycoprotein in Tumor Microenvironment

(2020) Kianna Robinson et al.   Frontiers in Oncology

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance

(2020) Yena Cho et al.   Frontiers in Oncology

Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro

(2020) Kyeong Seok Kim et al.   Frontiers in Oncology

Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms

(2019) JI YEONG KIM et al.   ANTICANCER RESEARCH

Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition

(2019) JI YEONG KIM et al.   ANTICANCER RESEARCH

Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead

(2018) Emanuela Martino et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma

(2018) J. M. Sivik et al.   SUPPORTIVE CARE IN CANCER

P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells

(2018) JI YEONG KIM et al.   ANTICANCER RESEARCH

Measurement of Rhodamine 123 in Three-Dimensional Organoids: A Novel Model for P-Glycoprotein Inhibitor Screening

(2016) Yuanjin Zhang et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis

(2016) Ji Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance

(2016) Kenichi Inoue et al.   BREAST CANCER RESEARCH AND TREATMENT

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade

(2016) Zhaolin Chen et al.   CANCER LETTERS

Rifamycins, Alone and in Combination

(2016) David M. Rothstein   Cold Spring Harbor Perspectives in Medicine

Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug–Drug Interactions with Rifamycins

(2014) Mario Regazzi et al.   CLINICAL PHARMACOKINETICS

Mitosis-Targeting Natural Products for Cancer Prevention and Therapy

(2012) Chinthalapally V. Rao et al.   CURRENT DRUG TARGETS